APO Research
Talk to an analyst

APO RESEARCH · REPORT

Assisted Reproduction Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Assisted Reproduction Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025186 pages

Choose your research edition.

Industry ResearchAssisted Reproduction Drug Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Assisted Reproduction Drug Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Assisted Reproduction Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Assisted Reproduction Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Assisted Reproduction Drug Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Assisted Reproduction Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Assisted Reproduction Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Assisted Reproduction Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Assisted Reproduction Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Assisted Reproduction Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Assisted Reproduction Drug include Ipsen Pharma Biotech, Zhejiang Xianju Pharmaceutical Co., Ltd., Solvay Pharma, Shanghai First Biochemical Pharmaceutical Co. LTD, Merck Sharp & Dohme, Merck Serono, Livzon Group and GenSci, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Assisted Reproduction Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Assisted Reproduction Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Assisted Reproduction Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Assisted Reproduction Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Assisted Reproduction Drug Segment by Company

Ipsen Pharma Biotech

Zhejiang Xianju Pharmaceutical Co., Ltd.

Solvay Pharma

Shanghai First Biochemical Pharmaceutical Co. LTD

Merck Sharp & Dohme

Merck Serono

Livzon Group

GenSci

Assisted Reproduction Drug Segment by Type

Progestogen Hormone

Human Choroinic Gonadotrophin

Gonadotropin Releasing Hormone

Follicle-stimulating Hormone

Assisted Reproduction Drug Segment by Application

Controlled Ovarian Hyperstimulation

luteal Support

Down Regultion

Induced Ovulation

Assisted Reproduction Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Assisted Reproduction Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Assisted Reproduction Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Assisted Reproduction Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Assisted Reproduction Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Assisted Reproduction Drug industry.

Chapter 3: Detailed analysis of Assisted Reproduction Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Assisted Reproduction Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Assisted Reproduction Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Progestogen Hormone Table 3. Key Players of Human Choroinic Gonadotrophin Table 4. Key Players of Gonadotropin Releasing Hormone Table 3. Key Players of Follicle-stimulating Hormone Table 4. Global Assisted Reproduction Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Controlled Ovarian Hyperstimulation Table 6. Key Players of luteal Support Table 7. Key Players of Down Regultion Table 8. Key Players of Induced Ovulation Table 9. Global Assisted Reproduction Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Assisted Reproduction Drug Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Assisted Reproduction Drug Market Share by Region (2021-2026) Table 12. Global Assisted Reproduction Drug Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Assisted Reproduction Drug Market Share by Region (2027-2032) Table 14. Assisted Reproduction Drug Industry Trends Table 15. Assisted Reproduction Drug Industry Drivers Table 16. Assisted Reproduction Drug Industry Opportunities and Challenges Table 17. Assisted Reproduction Drug Industry Restraints Table 18. Global Assisted Reproduction Drug Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Assisted Reproduction Drug Revenue Market Share by Company (2021-2026) Table 20. Global Assisted Reproduction Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Assisted Reproduction Drug Key Company Head Office and Area Served Table 22. Global Assisted Reproduction Drug Company, Product Type & Application Table 23. Global Assisted Reproduction Drug Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Assisted Reproduction Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Assisted Reproduction Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Assisted Reproduction Drug Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Assisted Reproduction Drug Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Assisted Reproduction Drug Revenue Market Share by Type (2021-2026) Table 30. Global Assisted Reproduction Drug Revenue Market Share by Type (2027-2032) Table 31. Global Assisted Reproduction Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Assisted Reproduction Drug Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Assisted Reproduction Drug Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Assisted Reproduction Drug Revenue Market Share by Application (2021-2026) Table 35. Global Assisted Reproduction Drug Revenue Market Share by Application (2027-2032) Table 36. Ipsen Pharma Biotech Company Information Table 37. Ipsen Pharma Biotech Business Overview Table 38. Ipsen Pharma Biotech Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Ipsen Pharma Biotech Assisted Reproduction Drug Product Portfolio Table 40. Ipsen Pharma Biotech Recent Development Table 41. Zhejiang Xianju Pharmaceutical Co., Ltd. Company Information Table 42. Zhejiang Xianju Pharmaceutical Co., Ltd. Business Overview Table 43. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Product Portfolio Table 45. Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Development Table 46. Solvay Pharma Company Information Table 47. Solvay Pharma Business Overview Table 48. Solvay Pharma Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Solvay Pharma Assisted Reproduction Drug Product Portfolio Table 50. Solvay Pharma Recent Development Table 51. Shanghai First Biochemical Pharmaceutical Co. LTD Company Information Table 52. Shanghai First Biochemical Pharmaceutical Co. LTD Business Overview Table 53. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Product Portfolio Table 55. Shanghai First Biochemical Pharmaceutical Co. LTD Recent Development Table 56. Merck Sharp & Dohme Company Information Table 57. Merck Sharp & Dohme Business Overview Table 58. Merck Sharp & Dohme Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Merck Sharp & Dohme Assisted Reproduction Drug Product Portfolio Table 60. Merck Sharp & Dohme Recent Development Table 61. Merck Serono Company Information Table 62. Merck Serono Business Overview Table 63. Merck Serono Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Merck Serono Assisted Reproduction Drug Product Portfolio Table 65. Merck Serono Recent Development Table 66. Livzon Group Company Information Table 67. Livzon Group Business Overview Table 68. Livzon Group Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Livzon Group Assisted Reproduction Drug Product Portfolio Table 70. Livzon Group Recent Development Table 71. GenSci Company Information Table 72. GenSci Business Overview Table 73. GenSci Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. GenSci Assisted Reproduction Drug Product Portfolio Table 75. GenSci Recent Development Table 76. North America Assisted Reproduction Drug Market Size by Type (2021-2026) & (US$ Million) Table 77. North America Assisted Reproduction Drug Market Size by Type (2027-2032) & (US$ Million) Table 78. North America Assisted Reproduction Drug Market Size by Application (2021-2026) & (US$ Million) Table 79. North America Assisted Reproduction Drug Market Size by Application (2027-2032) & (US$ Million) Table 80. North America Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Assisted Reproduction Drug Market Size by Country (2021-2026) Table 82. North America Assisted Reproduction Drug Market Size by Country (2027-2032) Table 83. Europe Assisted Reproduction Drug Market Size by Type (2021-2026) & (US$ Million) Table 84. Europe Assisted Reproduction Drug Market Size by Type (2027-2032) & (US$ Million) Table 85. Europe Assisted Reproduction Drug Market Size by Application (2021-2026) & (US$ Million) Table 86. Europe Assisted Reproduction Drug Market Size by Application (2027-2032) & (US$ Million) Table 87. Europe Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. Europe Assisted Reproduction Drug Market Size by Country (2021-2026) Table 89. Europe Assisted Reproduction Drug Market Size by Country (2027-2032) Table 90. China Assisted Reproduction Drug Market Size by Type (2021-2026) & (US$ Million) Table 91. China Assisted Reproduction Drug Market Size by Type (2027-2032) & (US$ Million) Table 92. China Assisted Reproduction Drug Market Size by Application (2021-2026) & (US$ Million) Table 93. China Assisted Reproduction Drug Market Size by Application (2027-2032) & (US$ Million) Table 94. Asia Assisted Reproduction Drug Market Size by Type (2021-2026) & (US$ Million) Table 95. Asia Assisted Reproduction Drug Market Size by Type (2027-2032) & (US$ Million) Table 96. Asia Assisted Reproduction Drug Market Size by Application (2021-2026) & (US$ Million) Table 97. Asia Assisted Reproduction Drug Market Size by Application (2027-2032) & (US$ Million) Table 98. Asia Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Asia Assisted Reproduction Drug Market Size by Country (2021-2026) Table 100. Asia Assisted Reproduction Drug Market Size by Country (2027-2032) Table 101. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Type (2021-2026) & (US$ Million) Table 102. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Type (2027-2032) & (US$ Million) Table 103. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Application (2021-2026) & (US$ Million) Table 104. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Application (2027-2032) & (US$ Million) Table 105. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country (2021-2026) Table 107. South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country (2027-2032) Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Assisted Reproduction Drug Product Image Figure 2. Global Assisted Reproduction Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Assisted Reproduction Drug Market Share by Type: 2025 VS 2032 Figure 4. Progestogen Hormone Image Figure 5. Human Choroinic Gonadotrophin Image Figure 6. Gonadotropin Releasing Hormone Image Figure 7. Follicle-stimulating Hormone Image Figure 8. Global Assisted Reproduction Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Assisted Reproduction Drug Market Share by Application: 2025 VS 2032 Figure 10. Controlled Ovarian Hyperstimulation Image Figure 11. luteal Support Image Figure 12. Down Regultion Image Figure 13. Induced Ovulation Image Figure 14. Global Assisted Reproduction Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 16. Global Assisted Reproduction Drug Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Assisted Reproduction Drug Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Assisted Reproduction Drug Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Assisted Reproduction Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Assisted Reproduction Drug Revenue Market Share by Type (2021-2032) Figure 23. Global Assisted Reproduction Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Assisted Reproduction Drug Revenue Market Share by Application (2021-2032) Figure 25. North America Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 26. North America Assisted Reproduction Drug Market Share by Type (2021-2032) Figure 27. North America Assisted Reproduction Drug Market Share by Application (2021-2032) Figure 28. North America Assisted Reproduction Drug Market Share by Country (2021-2032) Figure 29. United States Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 30. Canada Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 32. Europe Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 33. Europe Assisted Reproduction Drug Market Share by Type (2021-2032) Figure 34. Europe Assisted Reproduction Drug Market Share by Application (2021-2032) Figure 35. Europe Assisted Reproduction Drug Market Share by Country (2021-2032) Figure 36. Germany Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 37. France Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 39. Italy Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 40. Russia Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 42. China Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 43. China Assisted Reproduction Drug Market Share by Type (2021-2032) Figure 44. China Assisted Reproduction Drug Market Share by Application (2021-2032) Figure 45. Asia Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 46. Asia Assisted Reproduction Drug Market Share by Type (2021-2032) Figure 47. Asia Assisted Reproduction Drug Market Share by Application (2021-2032) Figure 48. Asia Assisted Reproduction Drug Market Share by Country (2021-2032) Figure 49. Japan Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 53. India Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 54. Australia Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Assisted Reproduction Drug Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Assisted Reproduction Drug Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Assisted Reproduction Drug Market Share by Country (2021-2032) Figure 59. Brazil Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 64. UAE Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 66. Chile Assisted Reproduction Drug Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Progestogen Hormone
  • Human Choroinic Gonadotrophin
  • Gonadotropin Releasing Hormone
  • Follicle-stimulating Hormone
Applications
  • Controlled Ovarian Hyperstimulation
  • luteal Support
  • Down Regultion
  • Induced Ovulation
Companies covered
  • Ipsen Pharma Biotech
  • Zhejiang Xianju Pharmaceutical Co., Ltd.
  • Solvay Pharma
  • Shanghai First Biochemical Pharmaceutical Co. LTD
  • Merck Sharp & Dohme
  • Merck Serono
  • Livzon Group
  • GenSci

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Assisted Reproduction Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Progestogen Hormone
  5. 1.2.3 Human Choroinic Gonadotrophin
  6. 1.2.4 Gonadotropin Releasing Hormone
  7. 1.2.5 Follicle-stimulating Hormone
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Assisted Reproduction Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Controlled Ovarian Hyperstimulation
  11. 1.3.3 luteal Support
  12. 1.3.4 Down Regultion
  13. 1.3.5 Induced Ovulation
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Assisted Reproduction Drug Growth Trends by Region
  16. 1.5.1 Global Assisted Reproduction Drug Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Assisted Reproduction Drug Market Size by Region (2021-2026)
  18. 1.5.3 Assisted Reproduction Drug Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Assisted Reproduction Drug Market Dynamics
  1. 2.1 Assisted Reproduction Drug Industry Trends
  2. 2.2 Assisted Reproduction Drug Industry Drivers
  3. 2.3 Assisted Reproduction Drug Industry Opportunities and Challenges
  4. 2.4 Assisted Reproduction Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Assisted Reproduction Drug Revenue by Company (2021-2026)
  2. 3.2 Global Assisted Reproduction Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Assisted Reproduction Drug Key Company Head office and Area Served
  4. 3.4 Global Assisted Reproduction Drug Company, Product Type & Application
  5. 3.5 Global Assisted Reproduction Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Assisted Reproduction Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Assisted Reproduction Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Assisted Reproduction Drug Tier 1, Tier 2, and Tier 3
4 Assisted Reproduction Drug Market by Type
  1. 4.1 Global Assisted Reproduction Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Assisted Reproduction Drug Market Size by Type (2021-2032)
  3. 4.3 Global Assisted Reproduction Drug Market Size Share by Type (2021-2032)
5 Assisted Reproduction Drug Market by Application
  1. 5.1 Global Assisted Reproduction Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Assisted Reproduction Drug Market Size by Application (2021-2032)
  3. 5.3 Global Assisted Reproduction Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Ipsen Pharma Biotech
  2. 6.1.1 Ipsen Pharma Biotech Company Information
  3. 6.1.2 Ipsen Pharma Biotech Business Overview
  4. 6.1.3 Ipsen Pharma Biotech Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Ipsen Pharma Biotech Assisted Reproduction Drug Product Portfolio
  6. 6.1.5 Ipsen Pharma Biotech Recent Developments
  7. 6.2 Zhejiang Xianju Pharmaceutical Co., Ltd.
  8. 6.2.1 Zhejiang Xianju Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Zhejiang Xianju Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Product Portfolio
  12. 6.2.5 Zhejiang Xianju Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Solvay Pharma
  14. 6.3.1 Solvay Pharma Company Information
  15. 6.3.2 Solvay Pharma Business Overview
  16. 6.3.3 Solvay Pharma Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Solvay Pharma Assisted Reproduction Drug Product Portfolio
  18. 6.3.5 Solvay Pharma Recent Developments
  19. 6.4 Shanghai First Biochemical Pharmaceutical Co. LTD
  20. 6.4.1 Shanghai First Biochemical Pharmaceutical Co. LTD Company Information
  21. 6.4.2 Shanghai First Biochemical Pharmaceutical Co. LTD Business Overview
  22. 6.4.3 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Product Portfolio
  24. 6.4.5 Shanghai First Biochemical Pharmaceutical Co. LTD Recent Developments
  25. 6.5 Merck Sharp & Dohme
  26. 6.5.1 Merck Sharp & Dohme Company Information
  27. 6.5.2 Merck Sharp & Dohme Business Overview
  28. 6.5.3 Merck Sharp & Dohme Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck Sharp & Dohme Assisted Reproduction Drug Product Portfolio
  30. 6.5.5 Merck Sharp & Dohme Recent Developments
  31. 6.6 Merck Serono
  32. 6.6.1 Merck Serono Company Information
  33. 6.6.2 Merck Serono Business Overview
  34. 6.6.3 Merck Serono Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Serono Assisted Reproduction Drug Product Portfolio
  36. 6.6.5 Merck Serono Recent Developments
  37. 6.7 Livzon Group
  38. 6.7.1 Livzon Group Company Information
  39. 6.7.2 Livzon Group Business Overview
  40. 6.7.3 Livzon Group Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Livzon Group Assisted Reproduction Drug Product Portfolio
  42. 6.7.5 Livzon Group Recent Developments
  43. 6.8 GenSci
  44. 6.8.1 GenSci Company Information
  45. 6.8.2 GenSci Business Overview
  46. 6.8.3 GenSci Assisted Reproduction Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GenSci Assisted Reproduction Drug Product Portfolio
  48. 6.8.5 GenSci Recent Developments
7 North America
  1. 7.1 North America Assisted Reproduction Drug Market Size (2021-2032)
  2. 7.2 North America Assisted Reproduction Drug Market Size by Type
  3. 7.2.1 North America Assisted Reproduction Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Assisted Reproduction Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Assisted Reproduction Drug Market Share by Type (2021-2032)
  6. 7.3 North America Assisted Reproduction Drug Market Size by Application
  7. 7.3.1 North America Assisted Reproduction Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Assisted Reproduction Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Assisted Reproduction Drug Market Share by Application (2021-2032)
  10. 7.4 North America Assisted Reproduction Drug Market Size by Country
  11. 7.4.1 North America Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Assisted Reproduction Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Assisted Reproduction Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Assisted Reproduction Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Assisted Reproduction Drug Market Size (2021-2032)
  2. 8.2 Europe Assisted Reproduction Drug Market Size by Type
  3. 8.2.1 Europe Assisted Reproduction Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Assisted Reproduction Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Assisted Reproduction Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Assisted Reproduction Drug Market Size by Application
  7. 8.3.1 Europe Assisted Reproduction Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Assisted Reproduction Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Assisted Reproduction Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Assisted Reproduction Drug Market Size by Country
  11. 8.4.1 Europe Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Assisted Reproduction Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Assisted Reproduction Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Assisted Reproduction Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Assisted Reproduction Drug Market Size (2021-2032)
  2. 9.2 China Assisted Reproduction Drug Market Size by Type
  3. 9.2.1 China Assisted Reproduction Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Assisted Reproduction Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Assisted Reproduction Drug Market Share by Type (2021-2032)
  6. 9.3 China Assisted Reproduction Drug Market Size by Application
  7. 9.3.1 China Assisted Reproduction Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Assisted Reproduction Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Assisted Reproduction Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Assisted Reproduction Drug Market Size (2021-2032)
  2. 10.2 Asia Assisted Reproduction Drug Market Size by Type
  3. 10.2.1 Asia Assisted Reproduction Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Assisted Reproduction Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Assisted Reproduction Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Assisted Reproduction Drug Market Size by Application
  7. 10.3.1 Asia Assisted Reproduction Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Assisted Reproduction Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Assisted Reproduction Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Assisted Reproduction Drug Market Size by Country
  11. 10.4.1 Asia Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Assisted Reproduction Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Assisted Reproduction Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Assisted Reproduction Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Assisted Reproduction Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Assisted Reproduction Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Assisted Reproduction Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Assisted Reproduction Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Assisted Reproduction Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst